4//SEC Filing
PHARMACYCLICS INC 4
Accession 0001209191-14-051260
CIK 0000949699operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 6:51 PM ET
Size
16.6 KB
Accession
0001209191-14-051260
Insider Transaction Report
Form 4
McGreivy Jesse
VP, Clinical Science
Transactions
- Exercise/Conversion
Common Stock
2014-08-07$61.60/sh+11,667$718,687→ 34,062 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-08-07−3,645→ 15,313 totalExercise: $25.33From: 2012-04-16Exp: 2022-04-16→ Common Stock (3,645 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2014-08-07−11,667→ 23,333 totalExercise: $61.60From: 2013-04-11Exp: 2026-10-26→ Common Stock (11,667 underlying) - Exercise/Conversion
Common Stock
2014-08-07−18,750→ 56,250 totalExercise: $89.52From: 2013-07-09Exp: 2023-07-09→ Common Stock (18,750 underlying) - Sale
Common Stock
2014-08-07$120.92/sh−34,062$4,118,610→ 0 total - Exercise/Conversion
Common Stock
2014-08-07$25.33/sh+3,645$92,328→ 3,645 total - Exercise/Conversion
Common Stock
2014-08-07$89.52/sh+18,750$1,678,500→ 22,395 total
Footnotes (3)
- [F1]The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.
- [F2]The option vests 6/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016. The vesting of the options are subject to satisfaction of certain performance criteria.
- [F3]The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on each of July 9, 2014, July 9, 2015; July 9, 2016; July 9, 2017. The vesting of the options is subject to satisfaction of certain performance criteria.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000949699
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 6:51 PM ET
- Size
- 16.6 KB